drugset / Trial / NCT00758420

Randomized, Single Blind, Placebo Controlled, to Evaluate Efficacy and Safety of Polidocanol Injectable Foam for Treatment of Symptomatic, Visible Varicose Veins With SFJ Incompetence

NCT00758420

Phase 2/3 Completed 77 enrolled Boston Scientific Corporation
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the effectiveness of polidocanol injectable foam in the relief of symptoms, improvement of appearance, and overall effectiveness and safety in the treatment of varicose veins compared to placebo.

Timeline

Start
2008-10
Primary completion
2009-07
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Polidocanol Other / unclassified 1 % Intravenous
Comparator Polidocanol Other / unclassified 15 ml Intravenous

Indications